Gene · 3595
Papers1,950
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,950
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
| The proportion of C1q-high and ISG15-high monocytes in the skin of patients with Behçet disease. | Front Pharmacol | 2023 | 36959847 | PubTator, text mining | PubMed |
| KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates. | Front Genet | 2023 | 36936440 | PubTator, text mining | PubMed |
| Macrophage-specific autophagy-related gene HSPB8 is involved in the macrophage polarization in atherosclerosis. | BMC Cardiovasc Disord | 2023 | 36934244 | PubTator, text mining | PubMed |
| IFNγ-induction of TH1-like regulatory T cells controls antiviral responses. | Nat Immunol | 2023 | 36928412 | PubTator, text mining | PubMed |
| STAT4 increases the phenotypic and functional heterogeneity of intestinal tissue-resident memory T cells. | Mucosal Immunol | 2023 | 36925068 | PubTator, text mining | PubMed |
| Imaging genetic association analysis of triple-negative breast cancer based on the integration of prior sample information. | Front Genet | 2023 | 36911413 | PubTator, text mining | PubMed |
| Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity. | Virol Sin | 2023 | 36907331 | PubTator, text mining | PubMed |
| KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans. | Cell Rep | 2023 | 36897779 | PubTator, text mining | PubMed |
| The protective effect of IL-12/23 neutralizing antibody in sarcopenia associated with dextran sulfate sodium-induced experimental colitis. | J Cachexia Sarcopenia Muscle | 2023 | 36872597 | PubTator, text mining | PubMed |
| Diagnosis of cerebral malaria: Tools to reduce Plasmodium falciparum associated mortality. | Front Cell Infect Microbiol | 2023 | 36844403 | PubTator, text mining | PubMed |
| Inborn Errors of Immunity Causing Pediatric Susceptibility to Fungal Diseases. | J Fungi (Basel) | 2023 | 36836264 | PubTator, text mining | PubMed |
| Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. | Int J Mol Sci | 2023 | 36835413 | PubTator, text mining | PubMed |
| Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 36835246 | PubTator, text mining | PubMed |
| Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification. | Cell Death Discov | 2023 | 36797242 | PubTator, text mining | PubMed |
| Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. | Int J Mol Sci | 2023 | 36769181 | PubTator, text mining | PubMed |
| CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease. | Int J Mol Sci | 2023 | 36769019 | PubTator, text mining | PubMed |
| Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. | Cells | 2023 | 36766795 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer. | Cancers (Basel) | 2023 | 36765579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3595/papers?page=9